热门资讯> 正文
BVS、MT和SPRC均为上市前涨幅股
2024-05-07 20:37
- Gainers: Clearmind Medicine (CMND) +50% Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD Treatment.
- FibroGen (FGEN) +22% Q1 earnings call release
- Bioventus (BVS) +20% Q1 earnings call release
- Zeta Global Holdings (ZETA) +19% Q1 earnings call release
- Oscar Health (OSCR) +17% Q1 earnings call release
- Golden Sun Health Technology (GSUN) +17% regains compliance with Nasdaq.
- Esperion Therapeutics (ESPR) +15% Q1 earnings call release
- Mueller Water (MWA) +15% names Marietta Edmunds Zakas as CEO
- Symbotic (SYM) +14% Q2 earnings call release
- Hims & Hers Health (HIMS) +13% Q1 earnings call release
- Mmtec (MTC) +12%.
- Thoughtworks (TWKS) +11% names new CEO as Guo Xiao steps down.
- SciSparc (SPRC) +10%.
- Jumia Technologies (JMIA) +10% Q1 earnings call release
- UBS Group (UBS) +9% stock jumps after Q1 returns to profit; maps out cost, capital plans.
More on premarket gainers & stock
- Bioventus Inc. 2023 Q4 - Results - Earnings Call Presentation
- Bioventus Inc. (BVS) Q4 2023 Earnings Call Transcript
- SciSparc to acquire vehicle importer AutoMax
- SciSparc gains on grant of patent for core technology in multiple jurisdictions in Europe
- Seeking Alpha’s Quant Rating on Bioventus
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
